STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Russell Investments Group, Ltd. | 1,382 | $14,690 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,507 | $111,689 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 47,271 | $502,491 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 2,834 | $29 | 0.00% |
| Legal & General Group Plc | 15,192 | $161,492 | 0.00% |
| STATE STREET CORP | 551,682 | $5,864,380 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10,566 | $112 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 48 | $510 | 0.00% |
| CREDIT SUISSE AG/ | 13,511 | $143,622 | 0.00% |
| CITIGROUP INC | 9,468 | $100,645 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 11,398 | $94,945 | 0.00% |
| GOLDMAN SACHS GROUP INC | 93,501 | $993,916 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 169,288 | $1,799,531 | 0.00% |
| AMALGAMATED BANK | 2,333 | $25 | 0.00% |
| Bank of New York Mellon Corp | 104,328 | $1,109,007 | 0.00% |
| Citadel Advisors | 10,400 | $110,552 | 0.00% |
| Nuveen Asset Management, LLC | 63,627 | $676,355 | 0.00% |
| Citadel Advisors | 172,298 | $1,831,527 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 27,487 | $292,187 | 0.00% |
External links
This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.